Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Thinking differently about treating neuropathic pain

Corey W. Hunter, MD
Conditions
April 25, 2012
Share
Tweet
Share

Pain, in any form, can present a difficult challenge for even the most astute pain physician.  The complexity of treating neuropathic or nerve pain stems from a variety of reasons, ranging from the lack of an obvious source of the pain to the inability of the patients to explain what ails them, to a arduous history that was poorly managed with the wrong medications, allowing the pain to progress to a seemingly unmanageable state.  Many people with neuropathic pain are often given escalating doses of opioids in a fleeting attempt to control their discomfort; it is not until much later that they will seek the help of a pain management specialist.

As many can attest, opioids are rarely a good choice for the sole treatment of neuropathic pain.  Neuropathic pain medications, which include certain antidepressants and antiepileptics (indicated for specific types of neuropathic pain), are rarely discussed with these patients in the early stages, and, unfortunately, are often first mentioned late in the disease’s progression.  Moreover, the mere suggestion of these medications for the treatment of neuropathic pain is often met with confusion and even mistrust toward the doctor by patients not appropriately counseled by their physicians, leading to reactions like:  “I’m not depressed,” or “I’m not crazy, I just need a higher dose of my medication…my pain is a ‘15’ on a scale of 1 to 10!”

The growing neuropathic pain epidemic has created an uphill battle for both patients and the physicians trying to help them.  Whereas nocioceptive pain can usually be pinpointed to an actual event (e.g., pain resulting from a broken arm), neuropathic pain can be vague and nondescript in nature.  For many physicians, there is no sense of need to tease out the details from the ambiguity; a prescription is provided for an opioid-pain killer and the patient is sent home.  Not only will the discomfort most likely continue, but now the patient is subjected to an unnecessary risk for prescription drug dependency–another epidemic unto itself.

Understanding what neuropathic pain is and how it might present itself are the first and most important things to consider.  If you believe your pain symptoms are neuropathic, you should ask your doctor these questions:

  • My pain is not getting better; could this be neuropathic pain?
  • The medications I am taking are not helping; could this be neuropathic pain?
  • Are these the appropriate medications for treating neuropathic pain?
  • How much experience or training do you have in treating neuropathic pain? Could I get a second opinion?
  • Is the medication you are giving me potentially addictive? What else should I know about these medications?
  • Can you explain how antidepressants and antiepileptics work to treat neuropathic pain?

Waiting to get appropriate care makes neuropathic pain harder to treat.  However, even severe cases of neuropathic pain can be managed effectively by an informed patient with the proper therapies.

Corey W. Hunter is a pain management specialist and serves on The Neuropathy Association’s Neuropathic Pain Management Medical Advisory Council.  

Submit a guest post and be heard on social media’s leading physician voice.

Prev

The coming changes in health care delivery

April 24, 2012 Kevin 37
…
Next

Lessons learned when a doctor sues an attorney

April 25, 2012 Kevin 12
…

Tagged as: Neurology

Post navigation

< Previous Post
The coming changes in health care delivery
Next Post >
Lessons learned when a doctor sues an attorney

ADVERTISEMENT

More in Conditions

  • Glioblastoma immunotherapy trial: a new breakthrough

    Hoag Memorial Hospital Presbyterian
  • New autism treatment guidelines expand options for families

    Carrie Friedman, NP
  • Is white coat hypertension harmless?

    Monzur Morshed, MD and Kaysan Morshed
  • Gen Z, ADHD, and divided attention in therapy

    Ronke Lawal
  • Early-onset breast cancer: a survivor’s story

    Sara Rands
  • Remote second opinions for equitable cancer care

    Yousuf Zafar, MD
  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
    • Glioblastoma immunotherapy trial: a new breakthrough

      Hoag Memorial Hospital Presbyterian | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • Glioblastoma immunotherapy trial: a new breakthrough

      Hoag Memorial Hospital Presbyterian | Conditions
    • Did the CDC just dismantle vaccine safety clarity?

      Ronald L. Lindsay, MD | Policy
    • New autism treatment guidelines expand options for families

      Carrie Friedman, NP | Conditions
    • Why visitor bans hurt patient care

      Emmanuel Chilengwe | Education
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 10 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
    • Glioblastoma immunotherapy trial: a new breakthrough

      Hoag Memorial Hospital Presbyterian | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • Glioblastoma immunotherapy trial: a new breakthrough

      Hoag Memorial Hospital Presbyterian | Conditions
    • Did the CDC just dismantle vaccine safety clarity?

      Ronald L. Lindsay, MD | Policy
    • New autism treatment guidelines expand options for families

      Carrie Friedman, NP | Conditions
    • Why visitor bans hurt patient care

      Emmanuel Chilengwe | Education
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Thinking differently about treating neuropathic pain
10 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...